Sale!

BCR-ABL Quantitative MRD Monitor Test

Original price was: R3,700.Current price is: R2,750.

-26%

The BCR-ABL Quantitative MRD Monitor Test provides crucial monitoring for patients undergoing leukemia treatment. This highly sensitive test detects minimal residual disease (MRD) – the small number of cancer cells that may remain after treatment. At only ZAR 2,750 (regularly ZAR 3,700), this test offers peace of mind by tracking treatment effectiveness and detecting potential relapse early. Using advanced Real Time PCR technology, our test delivers accurate, reliable results that help your healthcare team make informed decisions about your ongoing care. Available nationwide with convenient sample collection in Johannesburg, Cape Town, Durban, and Pretoria. Trust Oracle Genomics for precise monitoring that supports your journey to better health.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

BCR-ABL MRD Test R2
BCR-ABL Quantitative MRD Monitor Test
R3,700 Original price was: R3,700.R2,750Current price is: R2,750.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Monitor Your Leukemia Treatment with Precision and Confidence

Living with leukemia can feel overwhelming, but having clear, reliable information about your treatment’s effectiveness brings peace of mind. The BCR-ABL Quantitative MRD Monitor Test is your partner in tracking treatment success and detecting potential issues before they become serious concerns.

Understanding Your BCR-ABL MRD Test

This specialized test measures minimal residual disease (MRD) – the very small number of leukemia cells that might remain in your body after treatment. Think of it as a highly sensitive radar that can detect even the tiniest traces of cancer cells, giving you and your doctor the information needed to make the best decisions about your ongoing care.

Using advanced Real Time PCR technology, our test provides precise measurements that help determine if your treatment is working effectively or if adjustments might be needed.

Who Should Consider This Important Test?

This test is specifically designed for patients who are:

  • Currently undergoing treatment for chronic myeloid leukemia (CML)
  • Monitoring their response to tyrosine kinase inhibitor therapy
  • Concerned about potential treatment resistance
  • Working with their hematologist or oncologist to optimize treatment plans
  • Seeking reassurance about their treatment’s effectiveness

If you’re feeling uncertain about whether your treatment is working as well as it should, this test provides the clarity you need.

Why This Test Matters for Your Health Journey

Early detection of treatment response changes can make a significant difference in your health outcomes. The BCR-ABL MRD Monitor Test offers:

  • Peace of Mind: Know exactly how well your treatment is working
  • Early Warning: Detect potential issues before they become serious
  • Treatment Optimization: Help your doctor make informed decisions about your care
  • Reduced Anxiety: Replace uncertainty with clear, actionable information
  • Proactive Health Management: Take control of your treatment journey

Understanding Your Test Results

We know waiting for test results can be stressful. That’s why we provide:

  • Clear, Easy-to-Understand Reports: Your results will be presented in a way that’s easy for you and your doctor to interpret
  • Expert Analysis: Our specialized team ensures accurate interpretation of your MRD levels
  • Fast Turnaround: Samples collected Monday, Wednesday, or Friday by 9 am receive results the following Tuesday, Thursday, or Saturday
  • Professional Support: Your results come with the context needed to understand what they mean for your specific situation

Remember: Your test results are a tool to help guide your treatment, not a final verdict on your health journey.

Affordable, Value-Driven Pricing

Test Option Price Savings
Special Price ZAR 2,750 ZAR 950 savings
Regular Price ZAR 3,700

Considering the potential impact on your treatment effectiveness and long-term health outcomes, this test represents excellent value for your healthcare investment.

Why Trust Oracle Genomics?

We understand that when it comes to your health, you need complete confidence in your testing provider. That’s why we offer:

  • Nationwide Coverage: Convenient testing available throughout South Africa, including Johannesburg, Cape Town, Durban, and Pretoria
  • Medical Expertise: Specialized testing designed for hematology and oncology patients
  • Accuracy Guarantee: Advanced Real Time PCR technology ensures reliable, precise results
  • Patient-Focused Approach: We prioritize your comfort and understanding throughout the testing process
  • Professional Partnerships: We work closely with healthcare providers to support your complete care team

Sample Collection Information

Sample Required: 5 mL (3 mL minimum) whole blood or bone marrow in 1 Lavender Top (EDTA) tube

Important Notes: Ship refrigerated. DO NOT FREEZE. Duly filled MRD Requisition Form (Form 22) with historical data is mandatory for accurate analysis.

Take Control of Your Treatment Journey Today

Don’t let uncertainty about your treatment effectiveness add stress to your health journey. The BCR-ABL Quantitative MRD Monitor Test provides the clarity and confidence you deserve.

Limited Time Offer: Secure your special pricing of ZAR 2,750 while available. Regular price ZAR 3,700.

Convenient Nationwide Access: Available in Johannesburg, Cape Town, Durban, Pretoria and throughout South Africa.